RT Journal Article
SR Electronic
T1 Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease
JF Open Heart
JO Open Heart
FD British Cardiovascular Society
SP e000753
DO 10.1136/openhrt-2017-000753
VO 5
IS 1
A1 Tasalak Thonghong
A1 Ole De Backer
A1 Lars Søndergaard
YR 2018
UL http://openheart.bmj.com/content/5/1/e000753.abstract
AB New European guidelines on the management of valvular heart disease—supported by the European Society of Cardiology (ESC) and European Association of CardioThoracic Surgery (EACTS)—were recently published. Although these guidelines are very comprehensive, these typically are not very inviting to read. In this document, we aimed to distil all the information about transcatheter aortic valve replacement (TAVR) in the new 2017 ESC/EACTS guidelines to the essential and give additional comments on the position of TAVR in 2017.